Reconciliatoin of Stockholders' (Deficit) Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Equity Attributable to Internat’l Isotopes Shareholders	Total	Equity Attributable to Noncontrolling Interest
Beginning balance, value at Dec. 31, 2020	$ 4,243,443	$ 122,191,837	$ (125,861,734)	$ 573,546	$ 2,887,252	$ 2,313,706
Shares outstanding at Dec. 31, 2020	424,344,298
Shares issued under employee stock purchase plan	$ 2,117	6,878		8,995	8,995
Shares issued under employee stock purchase plan, shares	211,640
Stock grant	$ 1,183	(1,183)
Stock grant, shares	118,315
Stock in lieu of dividends on convertible preferred C	$ 13,982	193,498		207,480	207,480
Stock in lieu of dividends on convertible preferred C, shares	1,398,200
Shares issued for exercise of employee stock options	$ 17,991	(17,991)
Shares issued for exercise of employee stock options, shares	1,799,107
Warrant exercise	$ 326,214	(326,214)
Warrant exercises, shares	32,621,409
Conversion of preferred B stock	$ 875	174,125		175,000	175,000
Conversion of preferred B stock, shares	87,500
Stock based compensation		49,093		49,093	49,093
Net (loss) income			(782,539)	(782,539)	(669,996)	112,543
Conversion of preferred C stock	$ 2,500	22,500		25,000	25,000
Conversion of preferred C stock, shares	250,000
Ending balance, value at Jun. 30, 2021	$ 4,608,305	122,292,543	(126,644,273)	256,575	2,682,824	2,426,249
Shares outstanding at Jun. 30, 2021	460,830,469
Beginning balance, value at Mar. 31, 2021	$ 4,606,367	122,103,290	(126,462,886)	246,771	2,655,965	2,409,194
Shares outstanding at Mar. 31, 2021	460,636,690
Shares issued under employee stock purchase plan	$ 1,063	3,454		4,517	4,517
Shares issued under employee stock purchase plan, shares	106,279
Conversion of preferred B stock	$ 875	174,125		175,000	175,000
Conversion of preferred B stock, shares	87,500
Stock based compensation		11,674		11,674	11,674
Net (loss) income			(181,387)	(181,387)	(164,332)	17,055
Ending balance, value at Jun. 30, 2021	$ 4,608,305	122,292,543	(126,644,273)	256,575	2,682,824	$ 2,426,249
Shares outstanding at Jun. 30, 2021	460,830,469
Beginning balance, value at Dec. 31, 2021	$ 5,025,842	124,469,034	(126,764,081)	2,730,795	2,730,795
Shares outstanding at Dec. 31, 2021	502,584,176
Shares issued under employee stock purchase plan	$ 1,199	7,974		9,173	9,173
Shares issued under employee stock purchase plan, shares	119,910
Stock grant	$ 1,872	(1,872)
Stock grant, shares	187,231
Stock in lieu of dividends on convertible preferred C	$ 22,720	181,760		204,480	204,480
Stock in lieu of dividends on convertible preferred C, shares	2,271,980
Shares issued for exercise of employee stock options	$ 6,111	(6,111)
Shares issued for exercise of employee stock options, shares	611,111				1,000,000
Warrant exercise	$ 5,150	56,650		61,800	$ 61,800
Warrant exercises, shares	515,000
Conversion of preferred B stock	$ 84,375	590,625		675,000	675,000
Conversion of preferred B stock, shares	8,437,500
Stock based compensation		237,474		237,474	237,474
Net (loss) income			982,997	982,997	982,997
Ending balance, value at Jun. 30, 2022	$ 5,147,269	125,535,534	(125,781,084)	4,901,719	4,901,719
Shares outstanding at Jun. 30, 2022	514,726,908
Beginning balance, value at Mar. 31, 2022	$ 5,062,374	124,885,936	(125,509,036)	4,439,274	4,439,274
Shares outstanding at Mar. 31, 2022	506,237,443
Shares issued under employee stock purchase plan	$ 520	3,456		3,976	3,976
Shares issued under employee stock purchase plan, shares	51,965
Conversion of preferred B stock	$ 84,375	590,625		675,000	675,000
Conversion of preferred B stock, shares	8,437,500
Stock based compensation		55,517		55,517	55,517
Net (loss) income			(272,048)	(272,048)	(272,048)
Ending balance, value at Jun. 30, 2022	$ 5,147,269	$ 125,535,534	$ (125,781,084)	$ 4,901,719	$ 4,901,719
Shares outstanding at Jun. 30, 2022	514,726,908